載入中
NASDAQHealthcareBiotechnology
最新資料
US$3.77
+US$0.07 · +1.89%
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
前收盤價
US$3.77
+US$0.07 · +1.89%
盤中時間採用ET。市場資料可能有所延遲。
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
日內區間
目前US$3.77
52週區間
目前US$3.77
盤中時間採用ET。市場資料可能有所延遲。
CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and development of new therapeutic solutions for patients.
日內區間
目前US$3.77
52週區間
目前US$3.77
近期已公布業績
近期已公布業績
第三方分析師預期可能變動，並非 GoAI 建議。
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 1996年3月25日 | 2:1 | — | — |
已生效 1996年3月25日
2:1
報告持有此股票曝險的交易所交易基金。
Vanguard Morningstar Total Stock Market ETFVTI490.07萬0.00%2.3兆 USD0.03%US$381.94+0.63%
iShares Russell 2000 ETFIWM270.09萬0.00%787.4億 USD0.19%US$278.94+0.49%
Vanguard Extended Market ETFVXF148.73萬0.00%954億 USD0.05%US$235+0.80%
iShares Russell 2000 Growth ETFIWO109.51萬0.01%139.17億 USD0.24%US$356.78+0.94%
Vanguard Russell 2000 ETFVTWO71.58萬0.00%180億 USD0.06%US$112.66+0.50%
iShares Micro-Cap ETFIWC36.65萬0.03%13.17億 USD0.60%US$183+0.11%
EA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSM21萬0.18%1.17億 USD0.73%US$15.9402+0.25%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSC19.47萬0.02%10.45億 USD0.20%US$86.29+0.43%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFiShares Russell 2000 Growth ETFIWOVanguard Russell 2000 ETFVTWOiShares Micro-Cap ETFIWCEA Series Trust - EA Bridgeway Ultra-Small Company Market ETFBUSMGoldman Sachs ActiveBeta U.S. Small Cap Equity ETFGSSCAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
